Enzyme Replacement Therapy Market is expected to reach US$ 13.8 Bn by the end of 2028 - Comprehensive Research Report by FMI
12 janv. 2022 09h10 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
DUBAI, United Arab Emirates, Jan. 12, 2022 (GLOBE NEWSWIRE) -- The global Enzyme Replacement Therapy Market is set to be valued at US$ 9.3 Bn in 2022, and is predicted to expand at a CAGR of 6.7% to...
Global Enzyme Replacement Therapy Market to Reach $15.16 Billion By 2030: Allied Market Research
18 oct. 2021 09h45 HE
|
Allied Market Research
Portland, OR, Oct. 18, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Enzyme Replacement Therapy Market generated $7.78 billion in 2020, and is...
AzurRx BioPharma to Present at Investor Summit Group’s Q2 Virtual Investor Summit (May 17)
11 mai 2021 07h30 HE
|
AzurRx BioPharma, Inc.
DELRAY BEACH, Fla., May 11, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of...
Lysosomal Storage Diseases Therapeutics Market to reach US$ 15,792.6 Million globally by 2027 – Coherent Market Insights
25 mai 2020 10h02 HE
|
CMI
SEATTLE, May 25, 2020 (GLOBE NEWSWIRE) -- Lysosomal Storage Diseases (LSDs) are inherited disorders caused due to lack of specific enzymes that break down certain lipids or carbohydrates in the body...
U.S. Non-oncology Biopharmaceuticals Market to Surpass US$ 253.0 Billion by 2026
23 avr. 2019 08h45 HE
|
CMI
SEATTLE, April 23, 2019 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the U.S. non-oncology biopharmaceuticals market size is estimated to be valued at US$ 116.0 Billion in 2018, and is...
Global Metabolism Drugs Market to Surpass US$ 9.9 Billion by 2026 – Coherent Market Insights
16 juil. 2018 10h00 HE
|
Coherent Market Insights
Seattle, July 16, 2018 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global metabolism drugs market was valued at US$ 5,765.3 million in 2017 and is projected to exhibit a CAGR of...